Cocrystal Pharma, Inc. (Nasdaq: COCP) announced that James Martin, CFO and co-CEO, will present a Company overview and clinical progress update at NobleCon 21 - Noble Capital Markets 21st Emerging Growth Equity Conference.
The conference will take place on Wednesday, December 3, 2025, at 10:00 am Eastern time in Boca Raton, Florida.
Interested investors and guests can attend the conference at a discounted rate by registering with the code COCPNOBLECON.
Company Overview Presentation
James Martin will provide an overview of Cocrystal Pharma, Inc.'s operations and progress.
Clinical Progress Update
Attendees will receive updates on the clinical progress of the company's innovative antiviral treatments.
Discounted Conference Rate
Investors and guests of Cocrystal Pharma can attend the conference at a discounted rate by using the provided code.
- Cocrystal Pharma is set to showcase its advancements in developing antiviral treatments for challenging diseases at the Noble Capital Markets' conference.
- The conference provides a platform for the company to connect with investors and share updates on its clinical-stage biotechnology endeavors.
Cocrystal Pharma's participation in the Noble Capital Markets' conference highlights its commitment to innovation in addressing unmet medical needs through antiviral drug development.